Skip to Main Content
  • De novo once-monthly darbepoetin α treatment for the anemia of chronic kidney disease using a computerized algorithmic approach

    De novo once-monthly darbepoetin α treatment for the anemia of chronic kidney disease using a computerized algorithmic approach

  • The potential role of statins in contrast nephropathy

  • Risk of bleeding and restenosis among chronic kidney disease patients undergoing percutaneous coronary intervention

  • The safety of intravenous iron sucrose use in the elderly patient

  • Diabetic kidney disease: Chronic kidney disease and diabetes - Preface

    Diabetic kidney disease: Chronic kidney disease and diabetes - Preface

  • Modelling the effects of vascular stress in mesangial cells

    Modelling the effects of vascular stress in mesangial cells

  • Estimate of maintenance EPO to darbepoetin alfa dose conversion ratio in a hospital-based dialysis patient population

  • Combination therapy with an ACE inhibitor and an angiotensin receptor blocker for diabetic nephropathy: A meta-analysis

    Combination therapy with an ACE inhibitor and an angiotensin receptor blocker for diabetic nephropathy: A meta-analysis

  • Glibenclamide induces collagen iv catabolism in high glucose-stimulated mesangial cells

    Glibenclamide induces collagen iv catabolism in high glucose-stimulated mesangial cells

  • A new mesangial triumvirate: Sulfonylureas, their receptors and endosulfines

  • Chronic kidney disease - A disease domain complex

  • Prevention of hemodialysis-related muscle cramps by intradialytic use of sequential compression devices: A report of four cases

    Prevention of hemodialysis-related muscle cramps by intradialytic use of sequential compression devices: A report of four cases